| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.824 | 0.004 | 0.824 | 5 Hydroxytryptamine antagonist | 0.78 0.004 DBMET01732 0.641 0.005 DBMET01733 0.678 0.004 DBMET01734 0.672 0.004 DBMET01824 0.78 0.004 DBMET01825 0.678 0.004 DBMET01826 | ||
| 0.735 | 0.004 | 0.908 | 5 Hydroxytryptamine agonist | 0.908 0.003 DBMET01732 0.533 0.005 DBMET01733 0.531 0.005 DBMET01734 0.541 0.004 DBMET01824 0.908 0.003 DBMET01825 0.531 0.005 DBMET01826 | DBMET01825 | |
| 0.733 | 0.004 | 0.733 | Dopamine antagonist | 0.443 0.006 DBMET01732 0.69 0.004 DBMET01733 0.651 0.004 DBMET01734 0.733 0.004 DBMET01824 0.443 0.006 DBMET01825 0.651 0.004 DBMET01826 | ||
| 0.718 | 0.002 | 0.897 | Dopamine D1 antagonist | 0.406 0.004 DBMET01732 0.848 0.002 DBMET01733 0.708 0.002 DBMET01734 0.897 0.002 DBMET01824 0.406 0.004 DBMET01825 0.708 0.002 DBMET01826 | DBMET01824 | |
| 0.719 | 0.003 | 0.745 | 5 Hydroxytryptamine 2C antagonist | 0.745 0.003 DBMET01732 0.553 0.004 DBMET01733 0.364 0.006 DBMET01734 0.571 0.004 DBMET01824 0.745 0.003 DBMET01825 0.364 0.006 DBMET01826 | DBMET01825 | |
| 0.706 | 0.003 | 0.745 | Alpha 2a adrenoreceptor antagonist | 0.745 0.003 DBMET01732 0.693 0.003 DBMET01733 0.453 0.004 DBMET01734 0.702 0.003 DBMET01824 0.745 0.003 DBMET01825 0.453 0.004 DBMET01826 | DBMET01825 | |
| 0.706 | 0.004 | 0.706 | 5 Hydroxytryptamine 2 antagonist | 0.703 0.004 DBMET01732 0.579 0.005 DBMET01733 0.688 0.004 DBMET01734 0.593 0.004 DBMET01824 0.703 0.004 DBMET01825 0.688 0.004 DBMET01826 | ||
| 0.705 | 0.004 | 0.716 | 5 Hydroxytryptamine 2B antagonist | 0.716 0.003 DBMET01732 0.585 0.004 DBMET01733 0.713 0.004 DBMET01734 0.588 0.004 DBMET01824 0.716 0.003 DBMET01825 0.713 0.004 DBMET01826 | DBMET01825 | |
| 0.69 | 0.002 | 0.69 | 5 Hydroxytryptamine 1E antagonist | 0.493 0.004 DBMET01732 0.603 0.003 DBMET01733 0.357 0.009 DBMET01734 0.686 0.002 DBMET01824 0.493 0.004 DBMET01825 0.357 0.009 DBMET01826 | ||
| 0.687 | 0.003 | 0.706 | Alpha 2 adrenoreceptor antagonist | 0.706 0.003 DBMET01732 0.637 0.003 DBMET01733 0.377 0.005 DBMET01734 0.64 0.003 DBMET01824 0.706 0.003 DBMET01825 0.377 0.005 DBMET01826 | DBMET01825 | |
| 0.672 | 0.004 | 0.672 | Dopamine D4 antagonist | 0.284 0.008 DBMET01732 0.506 0.004 DBMET01733 0.194 0.013 DBMET01734 0.571 0.004 DBMET01824 0.284 0.008 DBMET01825 0.194 0.013 DBMET01826 | ||
| 0.669 | 0.004 | 0.669 | Alpha adrenoreceptor antagonist | 0.617 0.004 DBMET01732 0.62 0.004 DBMET01733 0.642 0.004 DBMET01734 0.616 0.004 DBMET01824 0.617 0.004 DBMET01825 0.642 0.004 DBMET01826 | ||
| 0.654 | 0.003 | 0.654 | 5 Hydroxytryptamine 1F antagonist | 0.619 0.004 DBMET01732 0.56 0.004 DBMET01733 0.36 0.005 DBMET01734 0.563 0.004 DBMET01824 0.619 0.004 DBMET01825 0.36 0.005 DBMET01826 | ||
| 0.66 | 0.009 | 0.704 | 5 Hydroxytryptamine release stimulant | 0.704 0.007 DBMET01732 0.607 0.014 DBMET01733 0.374 0.051 DBMET01734 0.688 0.008 DBMET01824 0.704 0.007 DBMET01825 0.374 0.051 DBMET01826 | DBMET01825 | |
| 0.644 | 0.004 | 0.644 | 5 Hydroxytryptamine 2A antagonist | 0.615 0.004 DBMET01732 0.521 0.004 DBMET01733 0.592 0.004 DBMET01734 0.53 0.004 DBMET01824 0.615 0.004 DBMET01825 0.592 0.004 DBMET01826 | ||
| 0.639 | 0.002 | 0.639 | 5 Hydroxytryptamine 3B antagonist | 0.311 0.003 DBMET01732 0.266 0.003 DBMET01733 0.086 0.006 DBMET01734 0.28 0.003 DBMET01824 0.311 0.003 DBMET01825 0.086 0.006 DBMET01826 | ||
| 0.64 | 0.006 | 0.64 | HERG channel blocker | 0.559 0.01 DBMET01732 0.373 0.033 DBMET01733 0.203 0.089 DBMET01734 0.366 0.034 DBMET01824 0.559 0.01 DBMET01825 0.203 0.089 DBMET01826 | ||
| 0.636 | 0.003 | 0.636 | Alpha 2b adrenoreceptor antagonist | 0.542 0.004 DBMET01732 0.595 0.003 DBMET01733 0.475 0.004 DBMET01734 0.593 0.004 DBMET01824 0.542 0.004 DBMET01825 0.475 0.004 DBMET01826 | ||
| 0.631 | 0.004 | 0.631 | Dopamine D2 antagonist | 0.399 0.007 DBMET01732 0.592 0.004 DBMET01733 0.616 0.004 DBMET01734 0.63 0.004 DBMET01824 0.399 0.007 DBMET01825 0.616 0.004 DBMET01826 | ||
| 0.621 | 0.004 | 0.621 | Antihistaminic | 0.338 0.008 DBMET01732 0.3 0.01 DBMET01733 0.463 0.005 DBMET01734 0.347 0.008 DBMET01824 0.338 0.008 DBMET01825 0.463 0.005 DBMET01826 | ||
| 0.619 | 0.004 | 0.619 | Histamine antagonist | 0.335 0.008 DBMET01732 0.281 0.011 DBMET01733 0.463 0.005 DBMET01734 0.327 0.009 DBMET01824 0.335 0.008 DBMET01825 0.463 0.005 DBMET01826 | ||
| 0.617 | 0.002 | 0.617 | 5 Hydroxytryptamine 3 antagonist | 0.429 0.003 DBMET01732 0.306 0.004 DBMET01733 0.304 0.004 DBMET01734 0.32 0.004 DBMET01824 0.429 0.003 DBMET01825 0.304 0.004 DBMET01826 | ||
| 0.608 | 0.003 | 0.608 | Alpha 2c adrenoreceptor antagonist | 0.451 0.004 DBMET01732 0.563 0.003 DBMET01733 0.41 0.004 DBMET01734 0.569 0.003 DBMET01824 0.451 0.004 DBMET01825 0.41 0.004 DBMET01826 | ||
| 0.608 | 0.003 | 0.615 | Histamine H1 receptor antagonist | 0.314 0.006 DBMET01732 0.377 0.005 DBMET01733 0.615 0.003 DBMET01734 0.398 0.005 DBMET01824 0.314 0.006 DBMET01825 0.615 0.003 DBMET01826 | DBMET01826 | |
| 0.599 | 0.003 | 0.599 | Dopamine D5 antagonist | 0.31 0.004 DBMET01732 0.454 0.003 DBMET01733 0.397 0.003 DBMET01734 0.477 0.003 DBMET01824 0.31 0.004 DBMET01825 0.397 0.003 DBMET01826 | ||
| 0.568 | 0.004 | 0.568 | 5 Hydroxytryptamine 1 antagonist | 0.381 0.007 DBMET01732 0.411 0.006 DBMET01733 0.213 0.015 DBMET01734 0.449 0.005 DBMET01824 0.381 0.007 DBMET01825 0.213 0.015 DBMET01826 | ||
| 0.571 | 0.009 | 0.571 | Potassium channel (Voltage-sensitive) blocker | 0.492 0.015 DBMET01732 0.322 0.043 DBMET01733 0.318 0.044 DBMET01824 0.492 0.015 DBMET01825 | ||
| 0.567 | 0.005 | 0.585 | Antiadrenergic | 0.585 0.005 DBMET01732 0.454 0.006 DBMET01733 0.556 0.005 DBMET01734 0.43 0.007 DBMET01824 0.585 0.005 DBMET01825 0.556 0.005 DBMET01826 | DBMET01825 | |
| 0.561 | 0.004 | 0.598 | Alpha 1 adrenoreceptor antagonist | 0.52 0.005 DBMET01732 0.501 0.005 DBMET01733 0.598 0.004 DBMET01734 0.493 0.005 DBMET01824 0.52 0.005 DBMET01825 0.598 0.004 DBMET01826 | DBMET01826 | |
| 0.559 | 0.005 | 0.572 | Anesthetic general | 0.397 0.017 DBMET01732 0.55 0.005 DBMET01733 0.252 0.05 DBMET01734 0.572 0.005 DBMET01824 0.397 0.017 DBMET01825 0.252 0.05 DBMET01826 | DBMET01824 | |
| 0.557 | 0.005 | 0.573 | Adrenaline antagonist | 0.573 0.005 DBMET01732 0.445 0.007 DBMET01733 0.549 0.005 DBMET01734 0.421 0.007 DBMET01824 0.573 0.005 DBMET01825 0.549 0.005 DBMET01826 | DBMET01825 | |
| 0.546 | 0.004 | 0.546 | 5 Hydroxytryptamine 7 antagonist | 0.4 0.005 DBMET01732 0.302 0.005 DBMET01733 0.074 0.035 DBMET01734 0.308 0.005 DBMET01824 0.4 0.005 DBMET01825 0.074 0.035 DBMET01826 | ||
| 0.564 | 0.025 | 0.851 | Antiobesity | 0.79 0.005 DBMET01732 0.428 0.056 DBMET01733 0.851 0.005 DBMET01734 0.426 0.056 DBMET01824 0.79 0.005 DBMET01825 0.851 0.005 DBMET01826 | DBMET01826 | |
| 0.53 | 0.003 | 0.53 | Dopamine D3 antagonist | 0.28 0.006 DBMET01732 0.437 0.004 DBMET01733 0.26 0.007 DBMET01734 0.479 0.004 DBMET01824 0.28 0.006 DBMET01825 0.26 0.007 DBMET01826 | ||
| 0.521 | 0.004 | 0.521 | 5 Hydroxytryptamine 1A antagonist | 0.367 0.007 DBMET01732 0.391 0.006 DBMET01733 0.217 0.013 DBMET01734 0.43 0.005 DBMET01824 0.367 0.007 DBMET01825 0.217 0.013 DBMET01826 | ||
| 0.509 | 0.004 | 0.509 | Alpha 1a adrenoreceptor antagonist | 0.503 0.004 DBMET01732 0.437 0.005 DBMET01733 0.293 0.009 DBMET01734 0.429 0.005 DBMET01824 0.503 0.004 DBMET01825 0.293 0.009 DBMET01826 | ||
| 0.507 | 0.003 | 0.507 | 5 Hydroxytryptamine 5A antagonist | 0.381 0.003 DBMET01732 0.292 0.004 DBMET01733 0.088 0.02 DBMET01734 0.363 0.004 DBMET01824 0.381 0.003 DBMET01825 0.088 0.02 DBMET01826 | ||
| 0.539 | 0.039 | 0.539 | Analgesic | 0.414 0.078 DBMET01732 0.439 0.069 DBMET01733 0.535 0.04 DBMET01734 0.452 0.064 DBMET01824 0.414 0.078 DBMET01825 0.535 0.04 DBMET01826 | ||
| 0.502 | 0.003 | 0.502 | 5 Hydroxytryptamine 1D antagonist | 0.335 0.004 DBMET01732 0.294 0.004 DBMET01733 0.086 0.028 DBMET01734 0.352 0.004 DBMET01824 0.335 0.004 DBMET01825 0.086 0.028 DBMET01826 | ||
| 0.5 | 0.011 | 0.5 | Potassium channel blocker | 0.381 0.026 DBMET01732 0.272 0.056 DBMET01733 0.263 0.06 DBMET01824 0.381 0.026 DBMET01825 | ||
| 0.509 | 0.022 | 0.567 | Spasmolytic | 0.379 0.045 DBMET01732 0.561 0.017 DBMET01733 0.432 0.034 DBMET01734 0.567 0.016 DBMET01824 0.379 0.045 DBMET01825 0.432 0.034 DBMET01826 | DBMET01824 | |
| 0.482 | 0.003 | 0.482 | 5 Hydroxytryptamine 1B antagonist | 0.351 0.004 DBMET01732 0.289 0.005 DBMET01733 0.08 0.034 DBMET01734 0.335 0.004 DBMET01824 0.351 0.004 DBMET01825 0.08 0.034 DBMET01826 | ||
| 0.465 | 0.004 | 0.465 | Acetylcholine M1 receptor antagonist | 0.313 0.012 DBMET01732 0.441 0.005 DBMET01733 0.462 0.004 DBMET01734 0.44 0.005 DBMET01824 0.313 0.012 DBMET01825 0.462 0.004 DBMET01826 | ||
| 0.458 | 0.003 | 0.458 | 5 Hydroxytryptamine 5 antagonist | 0.331 0.004 DBMET01732 0.259 0.004 DBMET01733 0.074 0.024 DBMET01734 0.307 0.004 DBMET01824 0.331 0.004 DBMET01825 0.074 0.024 DBMET01826 | ||
| 0.445 | 0.006 | 0.493 | Cholinergic antagonist | 0.384 0.009 DBMET01732 0.421 0.007 DBMET01733 0.493 0.005 DBMET01734 0.407 0.007 DBMET01824 0.384 0.009 DBMET01825 0.493 0.005 DBMET01826 | DBMET01826 | |
| 0.44 | 0.004 | 0.48 | Alpha 1b adrenoreceptor antagonist | 0.371 0.005 DBMET01732 0.4 0.005 DBMET01733 0.48 0.004 DBMET01734 0.388 0.005 DBMET01824 0.371 0.005 DBMET01825 0.48 0.004 DBMET01826 | DBMET01826 | |
| 0.439 | 0.006 | 0.468 | Acetylcholine antagonist | 0.38 0.009 DBMET01732 0.415 0.007 DBMET01733 0.468 0.005 DBMET01734 0.399 0.008 DBMET01824 0.38 0.009 DBMET01825 0.468 0.005 DBMET01826 | DBMET01826 | |
| 0.426 | 0.003 | 0.509 | Acetylcholine M4 receptor antagonist | 0.227 0.005 DBMET01732 0.211 0.005 DBMET01733 0.509 0.003 DBMET01734 0.215 0.005 DBMET01824 0.227 0.005 DBMET01825 0.509 0.003 DBMET01826 | DBMET01826 | |
| 0.419 | 0.004 | 0.419 | Toll-Like receptor antagonist | 0.391 0.004 DBMET01732 0.398 0.004 DBMET01733 0.412 0.004 DBMET01824 0.391 0.004 DBMET01825 | ||
| 0.409 | 0.004 | 0.409 | Alpha 1 adrenoreceptor agonist | 0.342 0.004 DBMET01732 0.39 0.004 DBMET01733 0.059 0.037 DBMET01734 0.358 0.004 DBMET01824 0.342 0.004 DBMET01825 0.059 0.037 DBMET01826 | ||
| 0.387 | 0.005 | 0.387 | 5 Hydroxytryptamine 1 agonist | 0.246 0.009 DBMET01732 0.151 0.014 DBMET01733 0.131 0.016 DBMET01734 0.184 0.012 DBMET01824 0.246 0.009 DBMET01825 0.131 0.016 DBMET01826 | ||
| 0.4 | 0.022 | 0.4 | Sigma receptor agonist | 0.206 0.06 DBMET01732 0.4 0.022 DBMET01733 0.171 0.073 DBMET01734 0.392 0.023 DBMET01824 0.206 0.06 DBMET01825 0.171 0.073 DBMET01826 | ||
| 0.382 | 0.005 | 0.382 | Nav1.1 sodium channel blocker | 0.365 0.005 DBMET01732 0.337 0.006 DBMET01733 0.193 0.02 DBMET01734 0.335 0.006 DBMET01824 0.365 0.005 DBMET01825 0.193 0.02 DBMET01826 | ||
| 0.355 | 0.003 | 0.85 | 5 Hydroxytryptamine 2C agonist | 0.85 0.002 DBMET01732 0.219 0.004 DBMET01733 0.186 0.004 DBMET01734 0.21 0.004 DBMET01824 0.85 0.002 DBMET01825 0.186 0.004 DBMET01826 | DBMET01825 | |
| 0.353 | 0.006 | 0.388 | Acetylcholine muscarinic antagonist | 0.247 0.015 DBMET01732 0.332 0.007 DBMET01733 0.388 0.005 DBMET01734 0.327 0.007 DBMET01824 0.247 0.015 DBMET01825 0.388 0.005 DBMET01826 | DBMET01826 | |
| 0.348 | 0.003 | 0.686 | 5 Hydroxytryptamine 2 agonist | 0.686 0.002 DBMET01732 0.243 0.004 DBMET01733 0.088 0.012 DBMET01734 0.245 0.004 DBMET01824 0.686 0.002 DBMET01825 0.088 0.012 DBMET01826 | DBMET01825 | |
| 0.348 | 0.004 | 0.375 | Alpha adrenoreceptor agonist | 0.375 0.004 DBMET01732 0.349 0.004 DBMET01733 0.061 0.054 DBMET01734 0.326 0.004 DBMET01824 0.375 0.004 DBMET01825 0.061 0.054 DBMET01826 | DBMET01825 | |
| 0.363 | 0.027 | 0.363 | Anticonvulsant | 0.258 0.054 DBMET01732 0.171 0.107 DBMET01733 0.194 0.087 DBMET01824 0.258 0.054 DBMET01825 | ||
| 0.396 | 0.063 | 0.442 | GABA C receptor rho-3 antagonist | 0.379 0.071 DBMET01732 0.442 0.044 DBMET01733 0.233 0.17 DBMET01734 0.396 0.063 DBMET01824 0.379 0.071 DBMET01825 0.233 0.17 DBMET01826 | DBMET01733 | |
| 0.335 | 0.007 | 0.335 | Nav1.3 sodium channel blocker | 0.203 0.023 DBMET01732 0.224 0.018 DBMET01733 0.228 0.017 DBMET01824 0.203 0.023 DBMET01825 | ||
| 0.32 | 0.003 | 0.32 | Acetylcholine M5 receptor antagonist | 0.216 0.004 DBMET01732 0.263 0.004 DBMET01733 0.318 0.003 DBMET01734 0.276 0.004 DBMET01824 0.216 0.004 DBMET01825 0.318 0.003 DBMET01826 | ||
| 0.317 | 0.005 | 0.317 | Alpha 1d adrenoreceptor antagonist | 0.249 0.007 DBMET01732 0.256 0.007 DBMET01733 0.188 0.01 DBMET01734 0.247 0.007 DBMET01824 0.249 0.007 DBMET01825 0.188 0.01 DBMET01826 | ||
| 0.314 | 0.005 | 0.314 | Dopamine agonist | 0.211 0.009 DBMET01732 0.294 0.005 DBMET01733 0.065 0.048 DBMET01734 0.287 0.005 DBMET01824 0.211 0.009 DBMET01825 0.065 0.048 DBMET01826 | ||
| 0.314 | 0.005 | 0.314 | Nav1.6 sodium channel blocker | 0.24 0.011 DBMET01732 0.231 0.012 DBMET01733 0.125 0.088 DBMET01734 0.243 0.01 DBMET01824 0.24 0.011 DBMET01825 0.125 0.088 DBMET01826 | ||
| 0.311 | 0.005 | 0.332 | 5 Hydroxytryptamine uptake inhibitor | 0.332 0.005 DBMET01732 0.158 0.015 DBMET01733 0.058 0.048 DBMET01734 0.164 0.014 DBMET01824 0.332 0.005 DBMET01825 0.058 0.048 DBMET01826 | DBMET01825 | |
| 0.314 | 0.013 | 0.314 | Nav1.2 sodium channel blocker | 0.232 0.025 DBMET01732 0.245 0.023 DBMET01733 0.236 0.024 DBMET01824 0.232 0.025 DBMET01825 | ||
| 0.299 | 0.005 | 0.309 | Acetylcholine agonist | 0.287 0.006 DBMET01732 0.177 0.019 DBMET01733 0.309 0.005 DBMET01734 0.17 0.021 DBMET01824 0.287 0.006 DBMET01825 0.309 0.005 DBMET01826 | DBMET01826 | |
| 0.304 | 0.012 | 0.304 | Toll-Like receptor 9 antagonist | 0.219 0.028 DBMET01732 0.254 0.02 DBMET01733 0.26 0.019 DBMET01824 0.219 0.028 DBMET01825 | ||
| 0.283 | 0.003 | 0.283 | Histamine H4 receptor antagonist | 0.165 0.004 DBMET01732 0.103 0.005 DBMET01733 0.057 0.022 DBMET01734 0.111 0.004 DBMET01824 0.165 0.004 DBMET01825 0.057 0.022 DBMET01826 | ||
| 0.292 | 0.024 | 0.292 | Diuretic | 0.18 0.054 DBMET01732 0.211 0.04 DBMET01733 0.264 0.028 DBMET01824 0.18 0.054 DBMET01825 | ||
| 0.268 | 0.005 | 0.268 | Dopamine uptake inhibitor | 0.134 0.012 DBMET01732 0.177 0.008 DBMET01733 0.19 0.007 DBMET01824 0.134 0.012 DBMET01825 | ||
| 0.296 | 0.035 | 0.343 | Tyrosine 3 hydroxylase inhibitor | 0.303 0.032 DBMET01732 0.339 0.019 DBMET01733 0.244 0.074 DBMET01734 0.343 0.018 DBMET01824 0.303 0.032 DBMET01825 0.244 0.074 DBMET01826 | DBMET01824 | |
| 0.35 | 0.092 | 0.372 | MAP kinase kinase 6 inhibitor | 0.372 0.076 DBMET01732 0.298 0.137 DBMET01733 0.286 0.149 DBMET01824 0.372 0.076 DBMET01825 | DBMET01825 | |
| 0.263 | 0.007 | 0.263 | 5 Hydroxytryptamine 1A agonist | 0.188 0.009 DBMET01732 0.089 0.018 DBMET01733 0.126 0.012 DBMET01734 0.1 0.015 DBMET01824 0.188 0.009 DBMET01825 0.126 0.012 DBMET01826 | ||
| 0.275 | 0.023 | 0.42 | Cholinergic | 0.268 0.025 DBMET01732 0.211 0.042 DBMET01733 0.42 0.009 DBMET01734 0.229 0.035 DBMET01824 0.268 0.025 DBMET01825 0.42 0.009 DBMET01826 | DBMET01826 | |
| 0.296 | 0.047 | 0.296 | 5 Hydroxytryptamine uptake stimulant | 0.282 0.055 DBMET01732 0.274 0.06 DBMET01733 0.29 0.05 DBMET01824 0.282 0.055 DBMET01825 | ||
| 0.291 | 0.045 | 0.3 | Psychostimulant | 0.3 0.043 DBMET01732 0.284 0.047 DBMET01733 0.265 0.053 DBMET01824 0.3 0.043 DBMET01825 | DBMET01825 | |
| 0.263 | 0.018 | 0.295 | Adenylate cyclase inhibitor | 0.17 0.034 DBMET01732 0.273 0.017 DBMET01733 0.295 0.014 DBMET01824 0.17 0.034 DBMET01825 | DBMET01824 | |
| 0.247 | 0.004 | 0.31 | Alpha 2 adrenoreceptor agonist | 0.31 0.003 DBMET01732 0.219 0.004 DBMET01733 0.07 0.032 DBMET01734 0.212 0.004 DBMET01824 0.31 0.003 DBMET01825 0.07 0.032 DBMET01826 | DBMET01825 | |
| 0.252 | 0.009 | 0.281 | Acetylcholine nicotinic antagonist | 0.281 0.008 DBMET01732 0.204 0.012 DBMET01733 0.141 0.023 DBMET01734 0.19 0.014 DBMET01824 0.281 0.008 DBMET01825 0.141 0.023 DBMET01826 | DBMET01825 | |
| 0.244 | 0.005 | 0.244 | Dopamine D4 agonist | 0.113 0.012 DBMET01732 0.101 0.014 DBMET01733 0.047 0.039 DBMET01734 0.111 0.013 DBMET01824 0.113 0.012 DBMET01825 0.047 0.039 DBMET01826 | ||
| 0.242 | 0.004 | 0.242 | 5 Hydroxytryptamine 6 antagonist | 0.242 0.004 DBMET01732 0.138 0.008 DBMET01733 0.06 0.037 DBMET01734 0.15 0.006 DBMET01824 0.242 0.004 DBMET01825 0.06 0.037 DBMET01826 | ||
| 0.319 | 0.088 | 0.343 | Vasodilator, peripheral | 0.343 0.077 DBMET01732 0.301 0.096 DBMET01733 0.32 0.087 DBMET01824 0.343 0.077 DBMET01825 | DBMET01825 | |
| 0.233 | 0.004 | 0.233 | 5 Hydroxytryptamine 3A antagonist | 0.17 0.004 DBMET01732 0.112 0.011 DBMET01733 0.069 0.044 DBMET01734 0.111 0.012 DBMET01824 0.17 0.004 DBMET01825 0.069 0.044 DBMET01826 | ||
| 0.232 | 0.007 | 0.263 | Neuronal nicotinic receptor antagonist | 0.263 0.006 DBMET01732 0.182 0.009 DBMET01733 0.121 0.017 DBMET01734 0.168 0.01 DBMET01824 0.263 0.006 DBMET01825 0.121 0.017 DBMET01826 | DBMET01825 | |
| 0.268 | 0.046 | 0.295 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.295 0.028 DBMET01732 0.213 0.131 DBMET01733 0.194 0.184 DBMET01734 0.229 0.098 DBMET01824 0.295 0.028 DBMET01825 0.194 0.184 DBMET01826 | DBMET01825 | |
| 0.224 | 0.005 | 0.263 | Acetylcholine nicotinic agonist | 0.263 0.004 DBMET01732 0.168 0.012 DBMET01733 0.074 0.065 DBMET01734 0.162 0.014 DBMET01824 0.263 0.004 DBMET01825 0.074 0.065 DBMET01826 | DBMET01825 | |
| 0.29 | 0.072 | 0.294 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.294 0.069 DBMET01732 0.277 0.082 DBMET01733 0.262 0.096 DBMET01824 0.294 0.069 DBMET01825 | DBMET01825 | |
| 0.27 | 0.057 | 0.27 | Gastrin inhibitor | 0.194 0.158 DBMET01732 0.217 0.124 DBMET01733 0.2 0.148 DBMET01824 0.194 0.158 DBMET01825 | ||
| 0.299 | 0.088 | 0.302 | Vasodilator, coronary | 0.249 0.136 DBMET01732 0.302 0.086 DBMET01733 0.3 0.087 DBMET01824 0.249 0.136 DBMET01825 | DBMET01733 | |
| 0.354 | 0.146 | 0.387 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.387 0.113 DBMET01732 0.387 0.113 DBMET01825 | DBMET01825 | |
| 0.21 | 0.005 | 0.26 | Acetylcholine muscarinic agonist | 0.153 0.01 DBMET01732 0.068 0.028 DBMET01733 0.26 0.004 DBMET01734 0.067 0.029 DBMET01824 0.153 0.01 DBMET01825 0.26 0.004 DBMET01826 | DBMET01826 | |
| 0.216 | 0.011 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.228 0.008 DBMET01732 0.172 0.025 DBMET01733 0.204 0.014 DBMET01824 0.228 0.008 DBMET01825 | DBMET01825 | |
| 0.209 | 0.005 | 0.233 | Adrenaline uptake inhibitor | 0.233 0.005 DBMET01732 0.136 0.011 DBMET01733 0.176 0.007 DBMET01734 0.138 0.011 DBMET01824 0.233 0.005 DBMET01825 0.176 0.007 DBMET01826 | DBMET01825 | |
| 0.205 | 0.004 | 0.219 | Toll-Like receptor 7 antagonist | 0.219 0.004 DBMET01732 0.131 0.009 DBMET01733 0.068 0.048 DBMET01734 0.135 0.008 DBMET01824 0.219 0.004 DBMET01825 0.068 0.048 DBMET01826 | DBMET01825 | |
| 0.284 | 0.083 | 0.284 | Nootropic | 0.263 0.097 DBMET01732 0.183 0.182 DBMET01824 0.263 0.097 DBMET01825 | ||
| 0.212 | 0.011 | 0.223 | MAP3K9 inhibitor | 0.223 0.009 DBMET01732 0.195 0.018 DBMET01733 0.173 0.032 DBMET01734 0.201 0.015 DBMET01824 0.223 0.009 DBMET01825 0.173 0.032 DBMET01826 | DBMET01825 | |
| 0.259 | 0.061 | 0.32 | DNA synthesis inhibitor | 0.32 0.037 DBMET01732 0.279 0.052 DBMET01733 0.204 0.117 DBMET01734 0.261 0.06 DBMET01824 0.32 0.037 DBMET01825 0.204 0.117 DBMET01826 | DBMET01825 | |
| 0.205 | 0.014 | 0.296 | Mediator release inhibitor | 0.122 0.045 DBMET01732 0.296 0.007 DBMET01733 0.255 0.009 DBMET01824 0.122 0.045 DBMET01825 | DBMET01733 | |
| 0.194 | 0.007 | 0.238 | Acetylcholine M2 receptor antagonist | 0.114 0.018 DBMET01732 0.158 0.01 DBMET01733 0.238 0.005 DBMET01734 0.157 0.01 DBMET01824 0.114 0.018 DBMET01825 0.238 0.005 DBMET01826 | DBMET01826 | |
| 0.221 | 0.036 | 0.221 | Antipruritic | 0.181 0.063 DBMET01732 0.212 0.041 DBMET01733 0.215 0.04 DBMET01824 0.181 0.063 DBMET01825 | ||
| 0.219 | 0.037 | 0.229 | 5 Hydroxytryptamine 3E antagonist | 0.229 0.029 DBMET01732 0.163 0.161 DBMET01733 0.176 0.118 DBMET01734 0.177 0.114 DBMET01824 0.229 0.029 DBMET01825 0.176 0.118 DBMET01826 | DBMET01825 | |
| 0.191 | 0.02 | 0.219 | Chemokine receptor antagonist | 0.219 0.015 DBMET01732 0.119 0.048 DBMET01733 0.107 0.057 DBMET01824 0.219 0.015 DBMET01825 | DBMET01825 | |
| 0.172 | 0.004 | 0.369 | 5 Hydroxytryptamine 2A agonist | 0.369 0.003 DBMET01732 0.158 0.005 DBMET01733 0.064 0.043 DBMET01734 0.166 0.005 DBMET01824 0.369 0.003 DBMET01825 0.064 0.043 DBMET01826 | DBMET01825 | |
| 0.173 | 0.007 | 0.173 | Histamine H2 receptor antagonist | 0.122 0.02 DBMET01732 0.128 0.017 DBMET01733 0.122 0.02 DBMET01824 0.122 0.02 DBMET01825 | ||
| 0.182 | 0.018 | 0.202 | Protein kinase C gamma inhibitor | 0.175 0.02 DBMET01732 0.18 0.019 DBMET01733 0.202 0.014 DBMET01824 0.175 0.02 DBMET01825 | DBMET01824 | |
| 0.173 | 0.009 | 0.173 | Acetylcholine M3 receptor agonist | 0.152 0.019 DBMET01732 0.141 0.024 DBMET01733 0.079 0.062 DBMET01734 0.132 0.028 DBMET01824 0.152 0.019 DBMET01825 0.079 0.062 DBMET01826 | ||
| 0.169 | 0.005 | 0.191 | Dopamine D2 agonist | 0.105 0.01 DBMET01732 0.191 0.005 DBMET01733 0.17 0.005 DBMET01824 0.105 0.01 DBMET01825 | DBMET01733 | |
| 0.176 | 0.015 | 0.257 | Protein kinase C zeta inhibitor | 0.159 0.018 DBMET01732 0.214 0.01 DBMET01733 0.257 0.007 DBMET01824 0.159 0.018 DBMET01825 | DBMET01824 | |
| 0.175 | 0.014 | 0.213 | Prolactin inhibitor | 0.151 0.022 DBMET01732 0.188 0.011 DBMET01733 0.099 0.056 DBMET01734 0.213 0.007 DBMET01824 0.151 0.022 DBMET01825 0.099 0.056 DBMET01826 | DBMET01824 | |
| 0.169 | 0.009 | 0.199 | Acetylcholine M3 receptor antagonist | 0.13 0.013 DBMET01732 0.199 0.007 DBMET01733 0.198 0.007 DBMET01734 0.184 0.008 DBMET01824 0.13 0.013 DBMET01825 0.198 0.007 DBMET01826 | DBMET01733 | |
| 0.161 | 0.005 | 0.161 | Nicotinic receptor alpha7 subunit antagonist | 0.149 0.006 DBMET01732 0.115 0.01 DBMET01733 0.102 0.012 DBMET01824 0.149 0.006 DBMET01825 | ||
| 0.155 | 0.007 | 0.194 | Acetylcholine M1 receptor agonist | 0.114 0.011 DBMET01732 0.037 0.036 DBMET01733 0.194 0.005 DBMET01734 0.114 0.011 DBMET01825 0.194 0.005 DBMET01826 | DBMET01826 | |
| 0.149 | 0.004 | 0.149 | 5 Hydroxytryptamine 7 agonist | 0.13 0.005 DBMET01732 0.126 0.005 DBMET01733 0.059 0.033 DBMET01734 0.143 0.004 DBMET01824 0.13 0.005 DBMET01825 0.059 0.033 DBMET01826 | ||
| 0.231 | 0.088 | 0.361 | Superoxide dismutase inhibitor | 0.361 0.034 DBMET01732 0.248 0.076 DBMET01733 0.285 0.056 DBMET01824 0.361 0.034 DBMET01825 | DBMET01825 | |
| 0.267 | 0.127 | 0.323 | Calcium channel activator | 0.323 0.07 DBMET01732 0.268 0.126 DBMET01733 0.242 0.157 DBMET01824 0.323 0.07 DBMET01825 | DBMET01825 | |
| 0.146 | 0.005 | 0.185 | Nicotinic neuronal receptor agonist | 0.185 0.004 DBMET01732 0.085 0.018 DBMET01733 0.08 0.021 DBMET01824 0.185 0.004 DBMET01825 | DBMET01825 | |
| 0.218 | 0.083 | 0.218 | MAP-kinase-activated kinase 5 inhibitor | 0.202 0.101 DBMET01732 0.212 0.09 DBMET01733 0.216 0.086 DBMET01824 0.202 0.101 DBMET01825 | ||
| 0.226 | 0.092 | 0.495 | Aldehyde oxidase inhibitor | 0.384 0.049 DBMET01733 0.495 0.034 DBMET01824 | DBMET01824 | |
| 0.158 | 0.027 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 DBMET01732 0.152 0.039 DBMET01733 0.151 0.041 DBMET01824 0.136 0.088 DBMET01825 | ||
| 0.139 | 0.01 | 0.199 | Nicotinic alpha4beta2 receptor antagonist | 0.199 0.004 DBMET01732 0.111 0.023 DBMET01733 0.136 0.011 DBMET01734 0.103 0.029 DBMET01824 0.199 0.004 DBMET01825 0.136 0.011 DBMET01826 | DBMET01825 | |
| 0.132 | 0.004 | 0.132 | 5 Hydroxytryptamine 4 antagonist | 0.095 0.008 DBMET01732 0.1 0.007 DBMET01733 0.097 0.007 DBMET01824 0.095 0.008 DBMET01825 | ||
| 0.146 | 0.019 | 0.146 | Acetylcholine release stimulant | 0.12 0.048 DBMET01732 0.109 0.068 DBMET01733 0.116 0.054 DBMET01824 0.12 0.048 DBMET01825 | ||
| 0.13 | 0.007 | 0.13 | 5 Hydroxytryptamine 3 agonist | 0.11 0.011 DBMET01732 0.1 0.015 DBMET01733 0.104 0.014 DBMET01824 0.11 0.011 DBMET01825 | ||
| 0.126 | 0.003 | 0.126 | Adenylate cyclase 1 inhibitor | 0.101 0.004 DBMET01732 0.117 0.003 DBMET01733 0.056 0.02 DBMET01734 0.118 0.003 DBMET01824 0.101 0.004 DBMET01825 0.056 0.02 DBMET01826 | ||
| 0.131 | 0.009 | 0.131 | Histamine H3 receptor antagonist | 0.064 0.021 DBMET01732 0.064 0.021 DBMET01825 | ||
| 0.129 | 0.008 | 0.129 | Acetylcholine M5 receptor agonist | 0.106 0.017 DBMET01732 0.082 0.032 DBMET01733 0.091 0.025 DBMET01824 0.106 0.017 DBMET01825 | ||
| 0.134 | 0.015 | 0.134 | Bromodomain-containing protein 2 inhibitor | 0.112 0.029 DBMET01732 0.093 0.051 DBMET01733 0.098 0.043 DBMET01824 0.112 0.029 DBMET01825 | ||
| 0.123 | 0.006 | 0.123 | Protein kinase C beta inhibitor | 0.119 0.008 DBMET01732 0.114 0.009 DBMET01733 0.122 0.007 DBMET01824 0.119 0.008 DBMET01825 | ||
| 0.12 | 0.009 | 0.12 | Dopamine transporter inhibitor | 0.093 0.013 DBMET01732 0.086 0.015 DBMET01733 0.043 0.04 DBMET01734 0.084 0.015 DBMET01824 0.093 0.013 DBMET01825 0.043 0.04 DBMET01826 | ||
| 0.117 | 0.006 | 0.117 | Nicotinic alpha7 receptor agonist | 0.099 0.01 DBMET01732 0.056 0.035 DBMET01733 0.061 0.03 DBMET01824 0.099 0.01 DBMET01825 | ||
| 0.205 | 0.1 | 0.231 | Vasodilator | 0.184 0.118 DBMET01732 0.23 0.082 DBMET01733 0.231 0.082 DBMET01824 0.184 0.118 DBMET01825 | DBMET01824 | |
| 0.107 | 0.004 | 0.107 | Acetylcholine M4 receptor agonist | 0.07 0.007 DBMET01732 0.034 0.019 DBMET01733 0.031 0.021 DBMET01824 0.07 0.007 DBMET01825 | ||
| 0.107 | 0.007 | 0.127 | Toll-Like receptor 8 antagonist | 0.127 0.005 DBMET01732 0.055 0.036 DBMET01824 0.127 0.005 DBMET01825 | DBMET01825 | |
| 0.112 | 0.014 | 0.112 | Protein kinase C eta inhibitor | 0.088 0.021 DBMET01732 0.108 0.015 DBMET01733 0.112 0.014 DBMET01824 0.088 0.021 DBMET01825 | ||
| 0.221 | 0.128 | 0.307 | Hypoxia-inducible factor 1 alpha inhibitor | 0.213 0.137 DBMET01732 0.277 0.078 DBMET01733 0.307 0.062 DBMET01824 0.213 0.137 DBMET01825 | DBMET01824 | |
| 0.096 | 0.005 | 0.096 | Prolactin release inhibitor | 0.089 0.007 DBMET01732 0.088 0.007 DBMET01733 0.084 0.009 DBMET01734 0.09 0.006 DBMET01824 0.089 0.007 DBMET01825 0.084 0.009 DBMET01826 | ||
| 0.098 | 0.007 | 0.098 | 5 Hydroxytryptamine 1B agonist | 0.081 0.012 DBMET01732 0.065 0.022 DBMET01733 0.074 0.015 DBMET01824 0.081 0.012 DBMET01825 | ||
| 0.098 | 0.007 | 0.098 | Acetylcholine M2 receptor agonist | 0.086 0.01 DBMET01732 0.076 0.016 DBMET01733 0.057 0.033 DBMET01734 0.072 0.018 DBMET01824 0.086 0.01 DBMET01825 0.057 0.033 DBMET01826 | ||
| 0.097 | 0.007 | 0.097 | Potassium channel small-conductance Ca-activated blocker | 0.081 0.01 DBMET01732 0.041 0.039 DBMET01733 0.049 0.026 DBMET01824 0.081 0.01 DBMET01825 | ||
| 0.099 | 0.01 | 0.109 | Cyclin-dependent kinase 6 inhibitor | 0.109 0.008 DBMET01732 0.07 0.031 DBMET01733 0.07 0.031 DBMET01824 0.109 0.008 DBMET01825 | DBMET01825 | |
| 0.11 | 0.025 | 0.14 | Glycine receptor antagonist | 0.14 0.01 DBMET01732 0.085 0.049 DBMET01733 0.072 0.071 DBMET01734 0.087 0.046 DBMET01824 0.14 0.01 DBMET01825 0.072 0.071 DBMET01826 | DBMET01825 | |
| 0.114 | 0.031 | 0.118 | Phosphodiesterase 6D inhibitor | 0.115 0.03 DBMET01733 0.118 0.027 DBMET01824 | DBMET01824 | |
| 0.108 | 0.029 | 0.158 | Opioid kappa receptor antagonist | 0.09 0.046 DBMET01732 0.145 0.017 DBMET01733 0.158 0.015 DBMET01824 0.09 0.046 DBMET01825 | DBMET01824 | |
| 0.091 | 0.012 | 0.091 | Potassium channel (Ca-activated) blocker | 0.083 0.016 DBMET01732 0.064 0.035 DBMET01733 0.062 0.038 DBMET01824 0.083 0.016 DBMET01825 | ||
| 0.143 | 0.066 | 0.143 | Pregnane X receptor agonist | 0.126 0.112 DBMET01732 0.123 0.12 DBMET01733 0.136 0.084 DBMET01824 0.126 0.112 DBMET01825 | ||
| 0.198 | 0.123 | 0.214 | Interleukin agonist | 0.214 0.108 DBMET01732 0.173 0.146 DBMET01824 0.214 0.108 DBMET01825 | DBMET01825 | |
| 0.08 | 0.005 | 0.08 | 5 Hydroxytryptamine 1D agonist | 0.036 0.016 DBMET01732 0.037 0.015 DBMET01824 0.036 0.016 DBMET01825 | ||
| 0.116 | 0.041 | 0.175 | Nitric-oxide synthase inhibitor | 0.175 0.015 DBMET01732 0.175 0.015 DBMET01825 | DBMET01825 | |
| 0.085 | 0.012 | 0.085 | CC chemokine 5 receptor antagonist | 0.078 0.014 DBMET01732 0.055 0.031 DBMET01733 0.053 0.033 DBMET01824 0.078 0.014 DBMET01825 | ||
| 0.076 | 0.005 | 0.301 | 5 Hydroxytryptamine 2B agonist | 0.301 0.002 DBMET01732 0.048 0.015 DBMET01733 0.041 0.022 DBMET01734 0.048 0.015 DBMET01824 0.301 0.002 DBMET01825 0.041 0.022 DBMET01826 | DBMET01825 | |
| 0.075 | 0.003 | 0.09 | Nicotinic alpha3beta4 receptor agonist | 0.09 0.003 DBMET01732 0.058 0.004 DBMET01733 0.034 0.015 DBMET01734 0.053 0.005 DBMET01824 0.09 0.003 DBMET01825 0.034 0.015 DBMET01826 | DBMET01825 | |
| 0.107 | 0.037 | 0.108 | ALK inhibitor | 0.108 0.036 DBMET01732 0.084 0.054 DBMET01733 0.078 0.063 DBMET01824 0.108 0.036 DBMET01825 | DBMET01825 | |
| 0.114 | 0.045 | 0.174 | Protein kinase C mu inhibitor | 0.174 0.017 DBMET01732 0.096 0.061 DBMET01733 0.099 0.058 DBMET01824 0.174 0.017 DBMET01825 | DBMET01825 | |
| 0.142 | 0.073 | 0.142 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 DBMET01732 0.123 0.092 DBMET01824 0.129 0.086 DBMET01825 | ||
| 0.107 | 0.04 | 0.128 | Histamine N-methyltransferase inhibitor | 0.128 0.024 DBMET01732 0.079 0.067 DBMET01733 0.097 0.049 DBMET01824 0.128 0.024 DBMET01825 | DBMET01825 | |
| 0.144 | 0.082 | 0.156 | GABA C receptor rho-2 antagonist | 0.156 0.066 DBMET01732 0.143 0.083 DBMET01733 0.141 0.087 DBMET01824 0.156 0.066 DBMET01825 | DBMET01825 | |
| 0.077 | 0.015 | 0.077 | Histamine agonist | 0.061 0.027 DBMET01732 0.061 0.027 DBMET01825 | ||
| 0.117 | 0.056 | 0.117 | Falcipain 3 inhibitor | |||
| 0.073 | 0.012 | 0.139 | Kinesin antagonist | 0.098 0.008 DBMET01732 0.061 0.014 DBMET01733 0.139 0.005 DBMET01734 0.072 0.012 DBMET01824 0.098 0.008 DBMET01825 0.139 0.005 DBMET01826 | DBMET01826 | |
| 0.073 | 0.012 | 0.139 | Kinesin-like protein 1 inhibitor | 0.098 0.008 DBMET01732 0.061 0.014 DBMET01733 0.139 0.005 DBMET01734 0.072 0.012 DBMET01824 0.098 0.008 DBMET01825 0.139 0.005 DBMET01826 | DBMET01826 | |
| 0.113 | 0.054 | 0.14 | Platelet activating factor beta antagonist | 0.106 0.059 DBMET01733 0.14 0.042 DBMET01734 0.085 0.074 DBMET01824 0.14 0.042 DBMET01826 | DBMET01826 | |
| 0.079 | 0.021 | 0.079 | Sigma receptor antagonist | 0.041 0.04 DBMET01732 0.057 0.03 DBMET01733 0.061 0.027 DBMET01824 0.041 0.04 DBMET01825 | ||
| 0.109 | 0.051 | 0.109 | Insulin receptor antagonist | 0.088 0.08 DBMET01732 0.088 0.08 DBMET01825 | ||
| 0.064 | 0.008 | 0.064 | Nerve growth factor antagonist | 0.049 0.02 DBMET01733 0.049 0.02 DBMET01824 | ||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase 11A inhibitor | 0.075 0.072 DBMET01824 | ||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase XI inhibitor | 0.075 0.072 DBMET01824 | ||
| 0.07 | 0.017 | 0.125 | Nicotinic receptor alpha4 subunit antagonist | 0.125 0.005 DBMET01732 0.054 0.027 DBMET01733 0.052 0.03 DBMET01824 0.125 0.005 DBMET01825 | DBMET01825 | |
| 0.1 | 0.048 | 0.146 | Opioid antagonist | 0.086 0.061 DBMET01732 0.14 0.029 DBMET01733 0.146 0.027 DBMET01824 0.086 0.061 DBMET01825 | DBMET01824 | |
| 0.064 | 0.013 | 0.064 | Dopamine D3 agonist | 0.049 0.02 DBMET01732 0.058 0.015 DBMET01733 0.058 0.015 DBMET01824 0.049 0.02 DBMET01825 | ||
| 0.107 | 0.056 | 0.31 | Bronchodilator | 0.083 0.082 DBMET01732 0.126 0.041 DBMET01733 0.31 0.009 DBMET01734 0.138 0.036 DBMET01824 0.083 0.082 DBMET01825 0.31 0.009 DBMET01826 | DBMET01826 | |
| 0.274 | 0.224 | 0.358 | Caspase 9 stimulant | 0.28 0.217 DBMET01732 0.358 0.139 DBMET01733 0.35 0.145 DBMET01824 0.28 0.217 DBMET01825 | DBMET01733 | |
| 0.104 | 0.055 | 0.202 | Creatine kinase inhibitor | 0.202 0.01 DBMET01733 0.184 0.013 DBMET01824 | DBMET01733 | |
| 0.053 | 0.004 | 0.061 | 5 Hydroxytryptamine 6 agonist | 0.061 0.004 DBMET01732 0.03 0.017 DBMET01733 0.035 0.011 DBMET01824 0.061 0.004 DBMET01825 | DBMET01825 | |
| 0.13 | 0.083 | 0.184 | Protein kinase stimulant | 0.184 0.048 DBMET01733 0.175 0.052 DBMET01824 | DBMET01733 | |
| 0.09 | 0.042 | 0.097 | CC chemokine receptor antagonist | 0.097 0.037 DBMET01732 0.097 0.037 DBMET01825 | DBMET01825 | |
| 0.113 | 0.068 | 0.113 | Platelet activating factor antagonist | 0.108 0.072 DBMET01733 0.097 0.081 DBMET01734 0.097 0.081 DBMET01826 | ||
| 0.169 | 0.124 | 0.187 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 DBMET01732 0.16 0.135 DBMET01733 0.187 0.104 DBMET01824 0.167 0.126 DBMET01825 | DBMET01824 | |
| 0.109 | 0.064 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.075 DBMET01733 0.113 0.058 DBMET01824 | DBMET01824 | |
| 0.048 | 0.005 | 0.064 | Nicotinic alpha4beta2 receptor agonist | 0.064 0.004 DBMET01732 0.036 0.01 DBMET01733 0.034 0.013 DBMET01824 0.064 0.004 DBMET01825 | DBMET01825 | |
| 0.061 | 0.019 | 0.076 | Nicotinic receptor alpha3 subunit antagonist | 0.076 0.014 DBMET01732 0.045 0.029 DBMET01733 0.045 0.029 DBMET01824 0.076 0.014 DBMET01825 | DBMET01825 | |
| 0.074 | 0.034 | 0.157 | CXC chemokine 4 receptor antagonist | 0.157 0.014 DBMET01732 0.057 0.044 DBMET01733 0.054 0.047 DBMET01824 0.157 0.014 DBMET01825 | DBMET01825 | |
| 0.074 | 0.035 | 0.074 | Glutamate (mGluR7) antagonist | 0.067 0.048 DBMET01733 0.07 0.043 DBMET01824 | ||
| 0.081 | 0.042 | 0.081 | MAP kinase 7 inhibitor | 0.078 0.052 DBMET01733 | ||
| 0.066 | 0.029 | 0.066 | Phosphodiesterase 1A inhibitor | |||
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | 0.116 0.089 DBMET01732 0.116 0.089 DBMET01825 | ||
| 0.042 | 0.007 | 0.042 | Protein kinase C beta I inhibitor | 0.038 0.011 DBMET01732 0.04 0.009 DBMET01733 0.041 0.008 DBMET01824 0.038 0.011 DBMET01825 | ||
| 0.098 | 0.064 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 DBMET01732 0.091 0.077 DBMET01733 0.146 0.023 DBMET01825 | DBMET01825 | |
| 0.084 | 0.05 | 0.097 | CC chemokine 5 receptor agonist | 0.089 0.039 DBMET01732 0.086 0.047 DBMET01733 0.097 0.025 DBMET01824 0.089 0.039 DBMET01825 | DBMET01824 | |
| 0.105 | 0.072 | 0.105 | Polo-like kinase-4 inhibitor | |||
| 0.05 | 0.019 | 0.052 | Histamine H1 receptor agonist | 0.052 0.016 DBMET01732 0.052 0.016 DBMET01825 | DBMET01825 | |
| 0.034 | 0.004 | 0.106 | Nicotinic alpha4 receptor agonist | 0.106 0.003 DBMET01732 0.018 0.009 DBMET01733 0.017 0.01 DBMET01824 0.106 0.003 DBMET01825 | DBMET01825 | |
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | |||
| 0.09 | 0.062 | 0.118 | Polo-like kinase-1 inhibitor | 0.118 0.031 DBMET01734 0.118 0.031 DBMET01826 | DBMET01826 | |
| 0.072 | 0.044 | 0.12 | Opioid mu receptor antagonist | 0.114 0.027 DBMET01733 0.12 0.025 DBMET01824 | DBMET01824 | |
| 0.116 | 0.089 | 0.135 | Sodium channel (voltage-gated) blocker | 0.135 0.067 DBMET01732 0.106 0.102 DBMET01734 0.135 0.067 DBMET01825 0.106 0.102 DBMET01826 | DBMET01825 | |
| 0.045 | 0.018 | 0.045 | Nociceptin (N/OFQ) receptor antagonist | 0.045 0.017 DBMET01732 0.03 0.028 DBMET01824 0.045 0.017 DBMET01825 | ||
| 0.042 | 0.015 | 0.042 | ATM kinase inhibitor | 0.034 0.032 DBMET01732 0.034 0.032 DBMET01825 | ||
| 0.074 | 0.047 | 0.085 | Glycine receptor agonist | 0.085 0.033 DBMET01732 0.085 0.033 DBMET01825 | DBMET01825 | |
| 0.039 | 0.013 | 0.039 | Sigma 2 receptor antagonist | 0.027 0.018 DBMET01733 0.038 0.013 DBMET01824 | ||
| 0.056 | 0.03 | 0.066 | Dipeptidyl peptidase inhibitor | 0.066 0.02 DBMET01732 0.066 0.02 DBMET01825 | DBMET01825 | |
| 0.063 | 0.038 | 0.073 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.069 0.029 DBMET01733 0.073 0.025 DBMET01824 | DBMET01824 | |
| 0.049 | 0.025 | 0.049 | Phosphodiesterase 6C inhibitor | 0.044 0.04 DBMET01733 0.045 0.036 DBMET01824 | ||
| 0.034 | 0.01 | 0.034 | 5 Hydroxytryptamine 1F agonist | |||
| 0.096 | 0.073 | 0.181 | Estrogen receptor beta antagonist | 0.102 0.06 DBMET01732 0.181 0.011 DBMET01733 0.178 0.012 DBMET01824 0.102 0.06 DBMET01825 | DBMET01733 | |
| 0.033 | 0.011 | 0.042 | Estrogen-related receptor gamma antagonist | 0.041 0.005 DBMET01733 0.042 0.005 DBMET01824 | DBMET01824 | |
| 0.061 | 0.039 | 0.079 | Androgen agonist | 0.054 0.05 DBMET01732 0.068 0.032 DBMET01733 0.079 0.025 DBMET01824 0.054 0.05 DBMET01825 | DBMET01824 | |
| 0.132 | 0.111 | 0.14 | Heat shock protein 70 antagonist | 0.134 0.101 DBMET01733 0.14 0.075 DBMET01824 | DBMET01824 | |
| 0.045 | 0.025 | 0.045 | Antidiuretic hormone antagonist | |||
| 0.076 | 0.056 | 0.137 | Estrogen receptor alpha antagonist | 0.085 0.042 DBMET01732 0.135 0.014 DBMET01733 0.137 0.014 DBMET01824 0.085 0.042 DBMET01825 | DBMET01824 | |
| 0.179 | 0.161 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.149 DBMET01732 0.185 0.149 DBMET01825 | DBMET01825 | |
| 0.073 | 0.056 | 0.073 | Vanilloid 4 agonist | |||
| 0.095 | 0.078 | 0.101 | Granulocyte macrophage colony stimulating factor antagonist | 0.101 0.07 DBMET01734 0.101 0.07 DBMET01826 | DBMET01826 | |
| 0.087 | 0.07 | 0.087 | Glutamate release inhibitor | |||
| 0.05 | 0.033 | 0.05 | Bromodomain-containing protein 3 inhibitor | |||
| 0.053 | 0.037 | 0.053 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.035 | 0.018 | 0.04 | Protein kinase C beta II inhibitor | 0.04 0.011 DBMET01732 0.033 0.021 DBMET01733 0.035 0.017 DBMET01824 0.04 0.011 DBMET01825 | DBMET01825 | |
| 0.042 | 0.026 | 0.088 | Dopamine D5 agonist | 0.088 0.005 DBMET01732 0.072 0.008 DBMET01733 0.08 0.006 DBMET01824 0.088 0.005 DBMET01825 | DBMET01825 | |
| 0.036 | 0.02 | 0.036 | Vasopressin 2 antagonist | |||
| 0.143 | 0.128 | 0.191 | Antimitotic | 0.191 0.089 DBMET01733 0.176 0.099 DBMET01824 | DBMET01733 | |
| 0.071 | 0.059 | 0.098 | Analgesic, opioid | 0.092 0.036 DBMET01733 0.098 0.032 DBMET01824 | DBMET01824 | |
| 0.066 | 0.055 | 0.097 | CXC chemokine receptor antagonist | 0.097 0.026 DBMET01732 0.097 0.026 DBMET01825 | DBMET01825 | |
| 0.099 | 0.087 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.058 | 0.048 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DBMET01732 0.059 0.046 DBMET01825 | DBMET01825 | |
| 0.03 | 0.019 | 0.03 | Vasopressin 1A antagonist | |||
| 0.044 | 0.034 | 0.044 | Farnesyltransferase inhibitor | |||
| 0.074 | 0.065 | 0.097 | MAP kinase kinase 7 inhibitor | 0.089 0.027 DBMET01732 0.088 0.028 DBMET01733 0.097 0.016 DBMET01824 0.089 0.027 DBMET01825 | DBMET01824 | |
| 0.059 | 0.05 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.051 | 0.042 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 DBMET01732 0.06 0.027 DBMET01734 0.052 0.04 DBMET01825 0.06 0.027 DBMET01826 | DBMET01826 | |
| 0.03 | 0.022 | 0.03 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.082 | 0.074 | 0.148 | Protein kinase C delta inhibitor | 0.118 0.038 DBMET01732 0.148 0.022 DBMET01734 0.118 0.038 DBMET01825 0.148 0.022 DBMET01826 | DBMET01826 | |
| 0.031 | 0.024 | 0.031 | Vasopressin 1 antagonist | |||
| 0.035 | 0.028 | 0.04 | 5-Alpha-reductase inhibitor | 0.04 0.024 DBMET01733 0.033 0.031 DBMET01824 | DBMET01733 | |
| 0.065 | 0.059 | 0.065 | Polo-like kinase-2 inhibitor | |||
| 0.042 | 0.036 | 0.05 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 DBMET01732 0.05 0.021 DBMET01825 | DBMET01825 | |
| 0.018 | 0.013 | 0.018 | Histamine H4 receptor agonist | |||
| 0.029 | 0.024 | 0.029 | Phosphodiesterase 6B inhibitor | |||
| 0.143 | 0.138 | 0.169 | Platelet aggregation inhibitor | 0.142 0.139 DBMET01732 0.169 0.107 DBMET01733 0.142 0.139 DBMET01734 0.142 0.139 DBMET01825 0.142 0.139 DBMET01826 | DBMET01733 | |
| 0.16 | 0.155 | 0.216 | ErbB-1 antagonist | 0.216 0.073 DBMET01733 0.187 0.105 DBMET01824 | DBMET01733 | |
| 0.022 | 0.019 | 0.022 | Phosphodiesterase 6G inhibitor | |||
| 0.022 | 0.019 | 0.022 | Phosphodiesterase 6H inhibitor | |||
| 0.018 | 0.015 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.018 0.016 DBMET01732 0.019 0.013 DBMET01733 0.018 0.016 DBMET01825 | DBMET01733 | |
| 0.014 | 0.012 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DBMET01732 0.014 0.012 DBMET01733 0.018 0.008 DBMET01824 0.014 0.013 DBMET01825 | DBMET01824 | |
| 0.036 | 0.035 | 0.036 | Neurokinin 1 antagonist | |||
| 0.018 | 0.018 | 0.024 | Nociceptin (N/OFQ) receptor agonist | 0.024 0.012 DBMET01732 0.024 0.012 DBMET01825 | DBMET01825 | |
| 0.012 | 0.012 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 DBMET01732 0.014 0.007 DBMET01825 | DBMET01825 | |
| 0.1 | 0.1 | 0.186 | Estrogen antagonist | 0.107 0.081 DBMET01732 0.185 0.015 DBMET01733 0.186 0.015 DBMET01824 0.107 0.081 DBMET01825 | DBMET01824 | |
| 0.06 | 0.061 | 0.081 | Protein kinase C alpha inhibitor | 0.081 0.033 DBMET01732 0.081 0.033 DBMET01825 | DBMET01825 | |
| 0.02 | 0.021 | 0.028 | Dopamine D1 agonist | 0.026 0.012 DBMET01733 0.028 0.01 DBMET01824 | DBMET01824 | |
| 0.01 | 0.013 | 0.013 | Melatonin 2 antagonist | 0.013 0.007 DBMET01732 0.013 0.007 DBMET01825 | DBMET01825 | |
| 0.099 | 0.103 | 0.133 | Alpha-N-acetylglucosaminidase inhibitor | 0.133 0.066 DBMET01732 0.133 0.066 DBMET01825 | DBMET01825 | |
| 0.057 | 0.061 | 0.066 | Bcl2 antagonist | 0.066 0.047 DBMET01733 | DBMET01733 | |
| 0.036 | 0.041 | 0.048 | Opioid kappa receptor agonist | 0.044 0.029 DBMET01733 0.048 0.025 DBMET01824 | DBMET01824 | |
| 0.068 | 0.075 | 0.125 | Adrenaline agonist | 0.107 0.032 DBMET01732 0.125 0.023 DBMET01733 0.113 0.029 DBMET01824 0.107 0.032 DBMET01825 | DBMET01733 | |
| 0.039 | 0.046 | 0.097 | Poly(ADP-ribose) polymerase inhibitor | 0.097 0.008 DBMET01732 0.08 0.01 DBMET01734 0.097 0.008 DBMET01825 0.08 0.01 DBMET01826 | DBMET01825 | |
| 0.032 | 0.04 | 0.044 | Vascular adhesion protein 1 inhibitor | 0.044 0.021 DBMET01732 0.044 0.021 DBMET01825 | DBMET01825 | |
| 0.053 | 0.061 | 0.056 | DNA gyrase inhibitor | 0.056 0.054 DBMET01732 0.056 0.054 DBMET01825 | DBMET01825 | |
| 0.098 | 0.107 | 0.153 | Cyclooxygenase 3 inhibitor | 0.153 0.046 DBMET01732 0.114 0.084 DBMET01733 0.126 0.07 DBMET01824 0.153 0.046 DBMET01825 | DBMET01825 | |
| 0.042 | 0.051 | 0.066 | Topoisomerase II beta inhibitor | 0.066 0.018 DBMET01732 0.045 0.043 DBMET01733 0.055 0.026 DBMET01824 0.066 0.018 DBMET01825 | DBMET01825 | |
| 0.058 | 0.068 | 0.063 | Calcium channel P-type blocker | 0.063 0.048 DBMET01732 0.063 0.048 DBMET01825 | DBMET01825 | |
| 0.139 | 0.149 | 0.155 | Focal adhesion kinase 2 inhibitor | 0.155 0.123 DBMET01732 0.155 0.123 DBMET01825 | DBMET01825 | |
| 0.023 | 0.035 | 0.041 | Endothelial nitric-oxide synthase inhibitor | 0.041 0.013 DBMET01732 0.041 0.013 DBMET01825 | DBMET01825 | |
| 0.077 | 0.089 | 0.092 | Thioredoxin inhibitor | 0.092 0.059 DBMET01733 0.09 0.063 DBMET01824 | DBMET01733 | |
| 0.084 | 0.1 | 0.174 | GABA receptor agonist | 0.174 0.025 DBMET01734 0.174 0.025 DBMET01826 | DBMET01826 | |
| 0.026 | 0.043 | 0.05 | Estrogen-related receptor beta antagonist | 0.043 0.009 DBMET01733 0.05 0.005 DBMET01824 | DBMET01824 | |
| 0.084 | 0.102 | 0.099 | Glutamate (mGluR7) agonist | 0.099 0.062 DBMET01732 0.099 0.062 DBMET01825 | DBMET01825 | |
| 0.043 | 0.062 | 0.094 | Opioid delta receptor antagonist | 0.091 0.032 DBMET01733 0.094 0.032 DBMET01824 | DBMET01824 | |
| 0.085 | 0.105 | 0.14 | GABA C receptor antagonist | 0.14 0.036 DBMET01732 0.14 0.036 DBMET01825 | DBMET01825 | |
| 0.067 | 0.086 | 0.134 | NMDA receptor antagonist | 0.134 0.03 DBMET01732 0.108 0.042 DBMET01733 0.108 0.042 DBMET01824 0.134 0.03 DBMET01825 | DBMET01825 | |
| 0.052 | 0.072 | 0.152 | NMDA 2 receptor antagonist | 0.152 0.016 DBMET01732 0.102 0.031 DBMET01733 0.098 0.033 DBMET01824 0.152 0.016 DBMET01825 | DBMET01825 | |
| 0.084 | 0.104 | 0.113 | Toll-Like receptor 4 antagonist | 0.106 0.061 DBMET01733 0.113 0.051 DBMET01824 | DBMET01824 | |
| 0.151 | 0.172 | 0.177 | DNA damaging | 0.177 0.137 DBMET01733 0.168 0.147 DBMET01824 | DBMET01733 | |
| 0.032 | 0.054 | 0.062 | Phenylethanolamine N methyltransferase inhibitor | 0.062 0.007 DBMET01732 0.062 0.007 DBMET01825 | DBMET01825 | |
| 0.026 | 0.052 | 0.079 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.079 0.009 DBMET01732 0.075 0.01 DBMET01734 0.079 0.009 DBMET01825 0.075 0.01 DBMET01826 | DBMET01825 | |
| 0.013 | 0.04 | 0.028 | Imidazoline I1 receptor antagonist | 0.028 0.008 DBMET01732 0.028 0.008 DBMET01825 | DBMET01825 | |
| 0.064 | 0.092 | 0.143 | MAP-kinase-activated kinase inhibitor | 0.143 0.017 DBMET01732 0.143 0.017 DBMET01825 | DBMET01825 | |
| 0.113 | 0.142 | 0.124 | Neuropeptide Y1 antagonist | 0.124 0.114 DBMET01732 0.124 0.114 DBMET01825 | DBMET01825 | |
| 0.052 | 0.084 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.065 0.042 DBMET01732 0.063 0.046 DBMET01733 0.067 0.039 DBMET01824 0.065 0.042 DBMET01825 | DBMET01824 | |
| 0.056 | 0.09 | 0.104 | Phospholipase D inhibitor | 0.104 0.012 DBMET01732 0.104 0.012 DBMET01825 | DBMET01825 | |
| 0.093 | 0.127 | 0.131 | NADPH oxidase inhibitor | 0.123 0.079 DBMET01733 0.131 0.07 DBMET01824 | DBMET01824 | |
| 0.085 | 0.122 | 0.102 | TRPA1 agonist | 0.102 0.084 DBMET01824 | DBMET01824 | |
| 0.063 | 0.1 | 0.113 | Inducible nitric-oxide synthase inhibitor | 0.113 0.028 DBMET01732 0.113 0.028 DBMET01825 | DBMET01825 | |
| 0.088 | 0.125 | 0.154 | Acetylcholinesterase inhibitor | 0.154 0.053 DBMET01734 0.103 0.101 DBMET01824 0.154 0.053 DBMET01826 | DBMET01826 | |
| 0.03 | 0.068 | 0.053 | Opioid agonist | 0.05 0.04 DBMET01733 0.053 0.036 DBMET01824 | DBMET01824 | |
| 0.072 | 0.11 | 0.157 | GABA C receptor agonist | 0.157 0.031 DBMET01732 0.157 0.031 DBMET01825 | DBMET01825 | |
| 0.03 | 0.068 | 0.047 | Opioid mu receptor agonist | 0.045 0.034 DBMET01733 0.047 0.032 DBMET01824 | DBMET01824 | |
| 0.126 | 0.165 | 0.178 | Phospholipase C inhibitor | 0.178 0.063 DBMET01732 0.139 0.131 DBMET01733 0.147 0.113 DBMET01824 0.178 0.063 DBMET01825 | DBMET01825 | |
| 0.07 | 0.114 | 0.087 | Phosphodiesterase 7B inhibitor | 0.087 0.075 DBMET01732 0.087 0.075 DBMET01825 | DBMET01825 | |
| 0.056 | 0.105 | 0.064 | MDM2 inhibitor | 0.064 0.059 DBMET01732 0.064 0.059 DBMET01825 | DBMET01825 | |
| 0.037 | 0.086 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 DBMET01732 0.066 0.037 DBMET01825 | DBMET01825 | |
| 0.04 | 0.09 | 0.072 | Cyclin-dependent kinase 4 inhibitor | 0.072 0.04 DBMET01732 0.072 0.04 DBMET01825 | DBMET01825 | |
| 0.021 | 0.073 | 0.038 | Alpha 1d adrenoreceptor agonist | 0.038 0.029 DBMET01732 0.038 0.029 DBMET01825 | DBMET01825 | |
| 0.107 | 0.159 | 0.128 | Adenylate cyclase stimulant | 0.128 0.106 DBMET01732 0.128 0.105 DBMET01824 0.128 0.106 DBMET01825 | DBMET01825 | |
| 0.025 | 0.077 | 0.04 | NMDA receptor subunit 3B antagonist | 0.04 0.034 DBMET01733 0.039 0.036 DBMET01824 | DBMET01733 | |
| 0.22 | 0.273 | 0.281 | 5 Hydroxytryptamine release inhibitor | 0.281 0.187 DBMET01732 0.242 0.239 DBMET01824 0.281 0.187 DBMET01825 | DBMET01825 | |
| 0.116 | 0.173 | 0.143 | P-glycoprotein inhibitor | 0.143 0.127 DBMET01824 | DBMET01824 | |
| 0.101 | 0.16 | 0.16 | NOS3 expression enhancer | 0.137 0.088 DBMET01733 0.16 0.063 DBMET01824 | DBMET01824 | |
| 0.073 | 0.135 | 0.096 | Alkylator | 0.096 0.093 DBMET01733 | DBMET01733 | |
| 0.045 | 0.108 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.043 DBMET01733 0.079 0.052 DBMET01824 | DBMET01733 | |
| 0.046 | 0.115 | 0.126 | MAP-kinase-activated kinase 2 inhibitor | 0.126 0.018 DBMET01732 0.126 0.018 DBMET01825 | DBMET01825 | |
| 0.02 | 0.092 | 0.07 | NMDA 2A receptor antagonist | 0.07 0.024 DBMET01732 0.07 0.024 DBMET01825 | DBMET01825 | |
| 0.06 | 0.135 | 0.158 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.158 0.044 DBMET01734 0.158 0.044 DBMET01826 | DBMET01826 | |
| 0.02 | 0.096 | 0.042 | Substance P antagonist | 0.042 0.024 DBMET01734 0.042 0.024 DBMET01826 | DBMET01826 | |
| 0.059 | 0.135 | 0.158 | Abl kinase inhibitor | 0.158 0.044 DBMET01734 0.158 0.044 DBMET01826 | DBMET01826 | |
| 0.062 | 0.139 | 0.138 | Topoisomerase II inhibitor | 0.122 0.065 DBMET01733 0.138 0.056 DBMET01824 | DBMET01824 | |
| 0.054 | 0.131 | 0.08 | Antineoplastic alkaloid | 0.08 0.065 DBMET01733 0.078 0.068 DBMET01824 | DBMET01733 | |
| 0.035 | 0.113 | 0.076 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.076 0.045 DBMET01734 0.076 0.045 DBMET01826 | DBMET01826 | |
| 0.062 | 0.141 | 0.097 | DNA intercalator | 0.097 0.077 DBMET01734 0.097 0.077 DBMET01826 | DBMET01826 | |
| 0.065 | 0.144 | 0.084 | Estrogen-related receptor beta agonist | 0.084 0.055 DBMET01733 0.083 0.056 DBMET01824 | DBMET01733 | |
| 0.037 | 0.117 | 0.083 | Check point kinase 1 inhibitor | 0.083 0.037 DBMET01732 0.083 0.037 DBMET01825 | DBMET01825 | |
| 0.116 | 0.199 | 0.174 | Neurotrophic factor enhancer | 0.148 0.141 DBMET01733 0.174 0.105 DBMET01824 | DBMET01824 | |
| 0.032 | 0.115 | 0.042 | Parathyroid hormone antagonist | 0.042 0.04 DBMET01732 0.042 0.04 DBMET01825 | DBMET01825 | |
| 0.166 | 0.253 | 0.23 | Histamine release inhibitor | 0.23 0.171 DBMET01824 | DBMET01824 | |
| 0.048 | 0.149 | 0.113 | Topoisomerase I inhibitor | 0.103 0.068 DBMET01733 0.113 0.06 DBMET01824 | DBMET01824 | |
| 0.028 | 0.136 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 DBMET01733 | DBMET01733 | |
| 0.055 | 0.169 | 0.112 | Cystathionine beta-synthase inhibitor | 0.099 0.078 DBMET01733 0.112 0.064 DBMET01824 | DBMET01824 | |
| 0.064 | 0.189 | 0.097 | Activin receptor-like kinase 4 inhibitor | 0.097 0.093 DBMET01732 0.097 0.093 DBMET01825 | DBMET01825 | |
| 0.044 | 0.172 | 0.081 | Pim-3 kinase inhibitor | 0.081 0.075 DBMET01732 0.081 0.075 DBMET01825 | DBMET01825 | |
| 0.029 | 0.166 | 0.079 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.079 0.051 DBMET01732 0.079 0.051 DBMET01825 | DBMET01825 | |
| 0.059 | 0.201 | 0.16 | Lipid peroxidase inhibitor | 0.153 0.066 DBMET01733 0.16 0.062 DBMET01824 | DBMET01824 | |
| 0.022 | 0.185 | 0.049 | Purinergic P2X4 antagonist | 0.049 0.026 DBMET01732 0.049 0.026 DBMET01825 | DBMET01825 | |
| 0.073 | 0.237 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.114 DBMET01733 | DBMET01733 | |
| 0.004 | 0.17 | 0.032 | Estrogen receptor beta agonist | 0.031 0.023 DBMET01733 0.032 0.023 DBMET01824 | DBMET01824 | |
| 0.056 | 0.234 | 0.099 | Alpha 2d adrenoreceptor antagonist | 0.099 0.049 DBMET01732 0.099 0.049 DBMET01825 | DBMET01825 | |
| 0.025 | 0.204 | 0.059 | Protein kinase C iota inhibitor | 0.059 0.041 DBMET01732 0.059 0.041 DBMET01825 | DBMET01825 | |
| 0.134 | 0.315 | 0.2 | Apoptosis antagonist | 0.198 0.181 DBMET01733 0.2 0.178 DBMET01824 | DBMET01824 | |
| 0.103 | 0.296 | 0.192 | 12-Lipoxygenase inhibitor | 0.192 0.161 DBMET01824 | DBMET01824 | |
| 0.008 | 0.205 | 0.057 | Estrogen agonist | 0.053 0.034 DBMET01733 0.057 0.032 DBMET01824 | DBMET01824 | |
| 0.003 | 0.21 | 0.029 | Estrogen receptor alpha agonist | 0.029 0.027 DBMET01824 | DBMET01824 | |
| 0.065 | 0.314 | 0.347 | Polo-like kinase-3 inhibitor | 0.347 0.005 DBMET01734 0.347 0.005 DBMET01826 | DBMET01826 | |
| 0.009 | 0.261 | 0.147 | Raf kinase B inhibitor | 0.147 0.014 DBMET01734 0.147 0.014 DBMET01826 | DBMET01826 | |
| 0.011 | 0.294 | 0.13 | Raf kinase inhibitor | 0.13 0.023 DBMET01734 0.13 0.023 DBMET01826 | DBMET01826 | |
| 0.124 | 0.413 | 0.257 | Apoptosis agonist | 0.251 0.213 DBMET01733 0.257 0.207 DBMET01824 | DBMET01824 | |
| 0.014 | 0.332 | 0.132 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.132 0.034 DBMET01734 0.132 0.034 DBMET01826 | DBMET01826 | |
| 0.017 | 0.421 | 0.051 | Alpha 1L adrenoreceptor agonist | 0.051 0.015 DBMET01732 0.051 0.015 DBMET01825 | DBMET01825 | |
| 0.018 | 0.51 | 0.113 | Ephrin antagonist | 0.113 0.054 DBMET01734 0.113 0.054 DBMET01826 | DBMET01826 | |
| 0.048 | 0.577 | 0.592 | Toll-Like receptor 7 agonist | 0.592 0.018 DBMET01734 0.592 0.018 DBMET01826 | DBMET01826 | |
| 0.045 | 0.586 | 0.584 | Toll-Like receptor agonist | 0.584 0.019 DBMET01734 0.584 0.019 DBMET01826 | DBMET01826 | |
| 0.092 | 0.665 | 0.288 | Calcium channel L-type activator | 0.288 0.168 DBMET01733 | DBMET01733 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |